Abstract P109: Serum Phosphorus Levels and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
Background - Several traditional cardiovascular risk factors, including hypertension, diabetes, and obesity have been associated with the risk of atrial fibrillation (AF). Literature on non-traditional risk predictors for AF is scarce, but high phosphorus, which has been linked with calcification and higher cardiovascular morbidity and mortality both in those with and without kidney dysfunction, may be one such marker. We assessed whether serum phosphorus levels were associated with AF incidence in a large community-based cohort in the US.
Methods - Our analysis included 14,693 participants (25% African-American, 45% men) free of AF at baseline (1987-89), and with measurements of fasting serum phosphorus from the Atherosclerosis Risk in Communities (ARIC) study. Incidence of AF was ascertained through the end of 2008 from study visit ECGs, hospitalizations and death certificates. Cox proportional hazard models were used to estimate the hazards ratios (HR) of AF by serum phosphorous levels, adjusting for potential confounders.
Results - During a median follow-up of 19.7 years, we identified 1659 incident AF cases. Higher serum phosphorus was associated with higher AF risk: multivariable HR: 1.20, 95% confidence interval (CI) 1.02-1.42 comparing extreme quintiles, p for trend=0.009 (table). The HR (95% CI) of AF with a 1 mg/dL increase in serum phosphorus was 1.15 (1.04-1.28). No significant interaction was seen by race (p=0.92) or gender (p=0.62). A possible interaction was seen between eGFR and phosphorus quintiles (p=0.05), with an increased risk of AF associated with higher serum phosphorus in those with eGFR =>90 mL/min/1.72m² but not among those with eGFR<90 (table).
Conclusion - In this large population-based study, higher levels of serum phosphorus were associated with a higher incidence of AF. The association was seen only in those with normal kidney function.
|Serum Phosphorus Quintiles (mg/dL)||P for trend|
|Hazard Ratio (95% CI)*||1 (Ref.)||1.09 (0.94-1.26)||1.06 (0.90-1.25)||1.22 (1.05-1.42)||1.20 (1.02-1.42)||0.009|
|eGFR = > 90 mL/min/1.72m²|
|Hazard Ratio (95% CI)*||1 (Ref.)||1.06 (0.88-1.28)||1.01 (0.82-1.25)||1.26 (1.04-1.52)||1.37 (1.11-1.69)||0.001|
|eGFR <90 mL/min/1.72m²|
|Hazard Ratio (95% CI)*||1 (Ref.)||1.11 (0.88-1.39)||1.14 (0.88-1.39)||1.17 (0.91-1.49)||1.01 (0.77-1.32)||0.69|
↵* Cox proportional hazard models adjusted for baseline age, gender, race, education, ARIC center, height, income, smoking status, drinking status, BMI, systolic blood pressure, diastolic blood pressure, antihypertensive medications, diabetes, serum calcium, estimated glomerular filtration rate (eGFR), prevalent stroke, prevalent heart failure and prevalent coronary heart disease
Funding(This research has received full or partial funding support from the American Heart Association, National Center)
- © 2012 by American Heart Association, Inc.